This segment focuses on the research, development, and manufacturing of pharmaceutical products targeting infectious diseases. It involves identifying novel drug targets, conducting preclinical and clinical trials, and ensuring regulatory compliance for market approval. The segment leverages advanced technologies in drug formulation and delivery to enhance efficacy and patient outcomes. Key activities include developing new antibiotics, antivirals, and antifungals to combat emerging and resistant pathogens. The ultimate goal is to provide effective treatments that reduce morbidity and mortality associated with infectious diseases, contributing to global public health.

This segment is dedicated to developing and commercializing pharmaceutical products for the treatment of cardiovascular and cerebrovascular diseases. Research efforts focus on identifying innovative therapeutic targets and developing novel drugs to address conditions such as hypertension, atherosclerosis, stroke, and heart failure. The segment utilizes advanced technologies in drug delivery and formulation to improve patient compliance and treatment outcomes. Clinical trials are conducted to evaluate the safety and efficacy of new therapies, with a strong emphasis on evidence-based medicine. The goal is to provide comprehensive solutions that improve cardiovascular health and reduce the burden of cardiovascular diseases on society.

This segment is dedicated to the research, development, and commercialization of innovative therapies for cancer treatment. It encompasses a wide range of activities, including drug discovery, preclinical studies, clinical trials, and regulatory affairs. The segment focuses on developing targeted therapies, immunotherapies, and chemotherapies to address various types of cancer. Advanced technologies such as genomics, proteomics, and bioinformatics are utilized to identify novel drug targets and personalize treatment approaches. Clinical trials are conducted to evaluate the safety and efficacy of new therapies, with a strong emphasis on improving patient outcomes and quality of life. The goal is to provide comprehensive solutions that transform cancer care and improve survival rates.

This segment focuses on the development and commercialization of pharmaceutical products for the treatment of metabolic and endocrine disorders, including diabetes, obesity, thyroid disorders, and hormonal imbalances. Research efforts are directed towards identifying novel therapeutic targets and developing innovative drugs to address these conditions. The segment utilizes advanced technologies in drug delivery and formulation to improve patient compliance and treatment outcomes. Clinical trials are conducted to evaluate the safety and efficacy of new therapies, with a strong emphasis on evidence-based medicine. The goal is to provide comprehensive solutions that improve metabolic health and reduce the burden of metabolic and endocrine diseases on society.